Clinical Trials · NCT04667377
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 387
- Start date
- Mar 2021
- Locations
- 43 sites, 12 countries
- Primary endpoint
- Percentage Change in Body Weight From Baseline to Week 46